The firm is ‘encouraged’ by the performance of the drug, both as monotherapy and in combination with semaglutide

The drug prevented more than 90% of precancerous sporadic adenomas in trials

The selective and reversible JAK inhibitor hit all goals in the Phase III Measure Up study

WM is a rare lymphoma representing around 1% of all non-Hodgkin lymphomas

Local pharmacies now gearing up to provide an increasing number of consultations as people encouraged to seek healthcare […]

Scientists from Rochester Institute of Technology and the University of Rochester aim to use virtual reality to help […]

Until there are effective treatments or vaccines, the COVID-19 pandemic will remain a significant threat to public health […]

Updated Date: Thu, 11 Jun 2020 00:00:00 EDT

Updated Date: Thu, 11 Jun 2020 00:00:00 EDT

Updated Date: Thu, 11 Jun 2020 00:00:00 EDT